ALACHUA, Fla.--(BUSINESS WIRE)--Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with three biomanufacturing contracts with a combined value of more than $16 million.
ALACHUA, Fla. – June 25, 2020 – Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract to advance development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). The contract ceiling value is $42.6 million.
Ology and Just - Evotech Collaborate to Develop Antibodies Against Coronavirus Partnership is part of a contract awarded to Ology Bioservices by the Department of Defense to develop and manufacture monoclonal antibodies for treatment and prevention of infection with Sars-CoV-2 Just – Evotec Biologics to supply antibody screening and analytical characterization of anti-covid-19 antibodies
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to Ology Bioservices Inc...
D. M. Berrie, R. C. Waters, C. Montoya, et al. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor. Vaccine, https://doi.org/10.1016/j.vaccine.2020.03.041 Read More >
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense...
Scholz I, Montoya C, Vela E. Examination of vesicular stomatitis virus-induced morphology changes in individual Vero cells by QMod microscopy. BioTechniques 68: 00-00 (June 2020) 10.2144/btn-2019-0137 Read More >
Government Contracts For Biodefense: The Benefits and Risks. Robert V. House, PhD, FATS, Senior Vice President of Government Contracts at Ology Bioservices shares his thoughts on the benefits of Government Contracting in an article recently published in the Washington Business Journal. Read it here
CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate Public Health Vaccine, LLC. will partner with Crozet Biopharma to develop the Nipah vaccine candidateUp to $9 million of this funding will go to Ology Bioservices, Inc., to support manufacturing and stockpiling of [...]
COVID-19 Letter